These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 9189840)

  • 61. Antiphospholipid antibodies in obstetrics: new complexities and sites of action.
    Caruso A; De Carolis S; Di Simone N
    Hum Reprod Update; 1999; 5(3):267-76. PubMed ID: 10438111
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Pregnancy outcome. Influence of antiphospholipid antibody titer, prior pregnancy losses and treatment.
    Reece EA; Garofalo J; Zheng XZ; Assimakopoulos E
    J Reprod Med; 1997 Jan; 42(1):49-55. PubMed ID: 9018646
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Postpartum thrombosis after a successful pregnancy in a recurrent aborter strongly positive for antiphospholipid antibodies.
    Katano K; Aoki K; Ogasawara M; Aoyama T; Suzumori K
    Acta Obstet Gynecol Scand; 1998 Mar; 77(3):354-6. PubMed ID: 9539288
    [No Abstract]   [Full Text] [Related]  

  • 64. Prevention of fetal death in the antiphospholipid antibody syndrome.
    Cowchock S
    Lupus; 1996 Oct; 5(5):467-72. PubMed ID: 8902784
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Neonatal and pregnancy outcome in primary antiphospholipid syndrome: a 10-year experience in one medical center.
    Chou AK; Hsieh SC; Su YN; Jeng SF; Chen CY; Chou HC; Tsao PN; Hsieh WS
    Pediatr Neonatol; 2009 Aug; 50(4):143-6. PubMed ID: 19750887
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Heparin or aspirin or both in the treatment of recurrent abortions in women with antiphospholipid antibody (syndrome).
    Hoppe B; Burmester GR; Dörner T
    Curr Opin Rheumatol; 2011 May; 23(3):299-304. PubMed ID: 21346577
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Combination of heparin and aspirin is superior to aspirin alone in enhancing live births in patients with recurrent pregnancy loss and positive anti-phospholipid antibodies: a meta-analysis of randomized controlled trials and meta-regression.
    Mak A; Cheung MW; Cheak AA; Ho RC
    Rheumatology (Oxford); 2010 Feb; 49(2):281-8. PubMed ID: 19965971
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Antiphospholipid syndrome. Proposition for management].
    Sagot P; Fiks-Sigaud M; Audrain M; Muller JY
    J Gynecol Obstet Biol Reprod (Paris); 1993; 22(3):293-9. PubMed ID: 8345153
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Low-molecular-weight heparin and aspirin use in relation to pregnancy outcome in women with systemic lupus erythematosus and antiphospholipid syndrome: A cohort study.
    Abheiden CN; Blomjous BS; Kroese SJ; Bultink IE; Fritsch-Stork RD; Lely AT; de Boer MA; de Vries JI
    Hypertens Pregnancy; 2017 Feb; 36(1):8-15. PubMed ID: 27599157
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment.
    Farquharson RG; Quenby S; Greaves M
    Obstet Gynecol; 2002 Sep; 100(3):408-13. PubMed ID: 12220757
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Efficacy of Different Treatment Regimens for Antiphospholipid Syndrome-related Recurrent Spontaneous Abortion.
    Ye SL; Gu XK; Tao LY; Cong JM; Wang YQ
    Chin Med J (Engl); 2017 Jun; 130(12):1395-1399. PubMed ID: 28584200
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Antiphospholipid antibodies as a cause of adverse pregnancy outcome. Therapeutic approach].
    Chernev T; Koleva R; Karag'ozova Zh; Chernev A
    Akush Ginekol (Sofiia); 2003; 42 Suppl 2():6-7. PubMed ID: 14619744
    [No Abstract]   [Full Text] [Related]  

  • 73. [Pregnancy and antiphospholipid syndrome].
    Costedoat-Chalumeau N; Guettrot-Imbert G; Leguern V; Leroux G; Le Thi Huong D; Wechsler B; Morel N; Vauthier-Brouzes D; Dommergues M; Cornet A; Aumaître O; Pourrat O; Piette JC; Nizard J
    Rev Med Interne; 2012 Apr; 33(4):209-16. PubMed ID: 22341691
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Recurrent pregnancy loss with antiphospholipid antibody: a systematic review of therapeutic trials.
    Empson M; Lassere M; Craig JC; Scott JR
    Obstet Gynecol; 2002 Jan; 99(1):135-44. PubMed ID: 11777524
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A favorable outcome of pregnancies in women with primary and secondary recurrent pregnancy loss associated with antiphospholipid syndrome.
    Diejomaoh MF; Al-Azemi MM; Bandar A; Egbase PE; Jirous J; Al-Othman S; Bukhadour N; Al-Sweih N
    Arch Gynecol Obstet; 2002 Apr; 266(2):61-6. PubMed ID: 12049296
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Risk Factors for Adverse Maternal and Fetal Outcomes in Women With Confirmed aPL Positivity: Results From a Multicenter Study of 283 Pregnancies.
    Fredi M; Andreoli L; Aggogeri E; Bettiga E; Lazzaroni MG; Le Guern V; Lojacono A; Morel N; Piette JC; Zatti S; Costedoat-Chalumeau N; Tincani A
    Front Immunol; 2018; 9():864. PubMed ID: 29867924
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Antiphospholipid syndrome in obstetrics].
    Corosu R; Roma B; Cocola M; Marziali M
    Minerva Ginecol; 1998; 50(1-2):9-13. PubMed ID: 9577149
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Pregnancy outcome in relation to uterine artery flow velocity waveforms and clinical characteristics in women with antiphospholipid syndrome.
    Caruso A; De Carolis S; Ferrazzani S; Valesini G; Caforio L; Mancuso S
    Obstet Gynecol; 1993 Dec; 82(6):970-7. PubMed ID: 8233274
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Adjusted prophylactic doses of nadroparin plus low dose aspirin therapy in obstetric antiphospholipid syndrome. A prospective cohort management study.
    Ruffatti A; Gervasi MT; Favaro M; Ruffatti AT; Hoxha A; Punzi L
    Clin Exp Rheumatol; 2011; 29(3):551-4. PubMed ID: 21640048
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Current insights in obstetric antiphospholipid syndrome.
    Schreiber K; Radin M; Sciascia S
    Curr Opin Obstet Gynecol; 2017 Dec; 29(6):397-403. PubMed ID: 28915160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.